サマリー

当レポートでは、米国における癌支持療法薬の市場規模および予測を掲載しています。
米国のがんサポーティブケア薬市場の収益、2016-2021年、2022-2027年、(百万ドル)
米国のがんサポーティブケア薬の上位5社の2020年の売上高(%)
世界のがんサポーティブケア薬の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに成長すると予想され、2021-2027年の間にXX％のCAGRで成長すると予想されます。
米国のがんサポーティブケア薬市場は、2020年にXX百万米ドルと評価され、予測期間中にXX％のCAGRで2027年にXX百万米ドルに達すると予測されています。
QYResearchは、がん支持療法薬の企業や業界専門家を対象に、収益、需要、製品タイプ、最近の開発・計画、業界動向、ドライバー、課題、障害、潜在的リスクなど、この業界に関する調査を行いました。
セグメント別の総市場。
米国のがん支持療法薬市場、タイプ別、2016-2021年、2022-2027年（単位：百万ドル）
米国がん支持療法薬市場セグメント別割合、タイプ別、2020年(%)
顆粒球コロニー刺激因子(G-CSFS)
エリスロポエチン刺激薬（ESAS)
制吐剤
ビスフォスフォネート
オピオイド
非ステロイド性抗炎症薬(NSAIDS)
その他

米国のがん支持療法薬市場、用途別、2016-2021年、2022-2027年（単位：百万ドル）
米国の癌支持療法薬市場セグメント別割合、用途別、2020年(%)
乳がん
肺がん
メラノーマ
前立腺癌
その他

競合他社の分析
本レポートでは、以下のような主要な市場参加者の分析も行っています。
主要企業の米国市場におけるがん支持療法薬の収益、2016-2021年（推定）、（百万ドル）
主要企業の米国市場におけるがん支持療法薬の収益シェア、2020年(%)
さらに、本レポートでは市場における競合他社のプロファイルを紹介しています。主なプレイヤーは以下の通りです。
アムジェン
ジョンソン・エンド・ジョンソン
ノバルティス
バクスター・インターナショナル
ファグロン・グループ
テバ・ファーマシューティカルズ・インダストリーズ
ホフマン・ラ・ロシュ社
アプライド・ファーマ・サイエンス・リサーチ
アカシア・ファーマ
協和発酵キリン
ヘルシン・ヘルスケア
ヘロンファーマ
メルク・アンド・カンパニー（Merck & Co.Inc.
サノフィ

ページTOPに戻る

目次

1 Introduction to Research & Analysis Reports
1.1 Cancer Supportive Care Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Cancer Supportive Care Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Cancer Supportive Care Drugs Overall Market Size
2.1 United States Cancer Supportive Care Drugs Market Size: 2021 VS 2027
2.2 United States Cancer Supportive Care Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Cancer Supportive Care Drugs Players in United States Market
3.2 Top United States Cancer Supportive Care Drugs Companies Ranked by Revenue
3.3 United States Cancer Supportive Care Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cancer Supportive Care Drugs Companies in United States Market, by Revenue in 2020
3.5 Companies Cancer Supportive Care Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Supportive Care Drugs Players in United States Market
3.6.1 List of Tier 1 Cancer Supportive Care Drugs Companies in United States
3.6.2 List of Tier 2 and Tier 3 Cancer Supportive Care Drugs Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Cancer Supportive Care Drugs Market Size Markets, 2021 & 2027
4.1.2 Granulocyte-Colony Stimulating Factors (G-CSFS)
4.1.3 Erythropoietin-Stimulating Agents (ESAS)
4.1.4 Antiemetics
4.1.5 Bisphosphonates
4.1.6 Opioids
4.1.7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
4.1.8 Others
4.2 By Type - United States Cancer Supportive Care Drugs Revenue & Forecasts
4.2.1 By Type - United States Cancer Supportive Care Drugs Revenue, 2016-2021
4.2.2 By Type - United States Cancer Supportive Care Drugs Revenue, 2022-2027
4.2.3 By Type - United States Cancer Supportive Care Drugs Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Cancer Supportive Care Drugs Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Melanoma
5.1.5 Prostate Cancer
5.1.6 Others
5.2 By Application - United States Cancer Supportive Care Drugs Revenue & Forecasts
5.2.1 By Application - United States Cancer Supportive Care Drugs Revenue, 2016-2021
5.2.2 By Application - United States Cancer Supportive Care Drugs Revenue, 2022-2027
5.2.3 By Application - United States Cancer Supportive Care Drugs Revenue Market Share, 2016-2027

6 Cancer Supportive Care Drugs Companies Profiles
6.1 Amgen
6.1.1 Amgen Company Details
6.1.2 Amgen Business Overview
6.1.3 Amgen Cancer Supportive Care Drugs Introduction
6.1.4 Amgen Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.1.5 Amgen Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Details
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Cancer Supportive Care Drugs Introduction
6.2.4 Johnson & Johnson Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.2.5 Johnson & Johnson Recent Developments
6.3 Novartis
6.3.1 Novartis Company Details
6.3.2 Novartis Business Overview
6.3.3 Novartis Cancer Supportive Care Drugs Introduction
6.3.4 Novartis Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.3.5 Novartis Recent Developments
6.4 Baxter International
6.4.1 Baxter International Company Details
6.4.2 Baxter International Business Overview
6.4.3 Baxter International Cancer Supportive Care Drugs Introduction
6.4.4 Baxter International Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.4.5 Baxter International Recent Developments
6.5 Fagron Group
6.5.1 Fagron Group Company Details
6.5.2 Fagron Group Business Overview
6.5.3 Fagron Group Cancer Supportive Care Drugs Introduction
6.5.4 Fagron Group Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.5.5 Fagron Group Recent Developments
6.6 Teva Pharmaceuticals Industries
6.6.1 Teva Pharmaceuticals Industries Company Details
6.6.2 Teva Pharmaceuticals Industries Business Overview
6.6.3 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Introduction
6.6.4 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.6.5 Teva Pharmaceuticals Industries Recent Developments
6.7 F.Hoffmann La-Roche Ltd
6.7.1 F.Hoffmann La-Roche Ltd Company Details
6.7.2 F.Hoffmann La-Roche Ltd Business Overview
6.7.3 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Introduction
6.7.4 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.7.5 F.Hoffmann La-Roche Ltd Recent Developments
6.8 Apr Applied Pharma Science Research
6.8.1 Apr Applied Pharma Science Research Company Details
6.8.2 Apr Applied Pharma Science Research Business Overview
6.8.3 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Introduction
6.8.4 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.8.5 Apr Applied Pharma Science Research Recent Developments
6.9 Acacia Pharma
6.9.1 Acacia Pharma Company Details
6.9.2 Acacia Pharma Business Overview
6.9.3 Acacia Pharma Cancer Supportive Care Drugs Introduction
6.9.4 Acacia Pharma Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.9.5 Acacia Pharma Recent Developments
6.10 Kyowa Hakko Kirin
6.10.1 Kyowa Hakko Kirin Company Details
6.10.2 Kyowa Hakko Kirin Business Overview
6.10.3 Kyowa Hakko Kirin Cancer Supportive Care Drugs Introduction
6.10.4 Kyowa Hakko Kirin Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.10.5 Kyowa Hakko Kirin Recent Developments
6.11 Helsinn Healthcare
6.11.1 Helsinn Healthcare Company Details
6.11.2 Helsinn Healthcare Business Overview
6.11.3 Helsinn Healthcare Cancer Supportive Care Drugs Introduction
6.11.4 Helsinn Healthcare Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.11.5 Helsinn Healthcare Recent Developments
6.12 Heron Pharma
6.12.1 Heron Pharma Company Details
6.12.2 Heron Pharma Business Overview
6.12.3 Heron Pharma Cancer Supportive Care Drugs Introduction
6.12.4 Heron Pharma Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.12.5 Heron Pharma Recent Developments
6.13 Merck & Co. Inc
6.13.1 Merck & Co. Inc Company Details
6.13.2 Merck & Co. Inc Business Overview
6.13.3 Merck & Co. Inc Cancer Supportive Care Drugs Introduction
6.13.4 Merck & Co. Inc Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.13.5 Merck & Co. Inc Recent Developments
6.14 Sanofi
6.14.1 Sanofi Company Details
6.14.2 Sanofi Business Overview
6.14.3 Sanofi Cancer Supportive Care Drugs Introduction
6.14.4 Sanofi Cancer Supportive Care Drugs Revenue in United States Market (2016-2021)
6.14.5 Sanofi Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer